Ching M S, Morgan D J, Smallwood R A
University of Melbourne Department of Medicine, Austin Hospital, Victoria, Australia.
J Pharmacol Exp Ther. 1989 Sep;250(3):1048-54.
Various kinetic models have been developed to describe the elimination of substances by the liver, but there is no agreement about which model is the most appropriate, as experimental evaluation is incomplete and results conflict. We have shown previously that hepatic elimination of taurocholate is best described by models that embody a high degree of sinusoidal heterogeneity or mixing, whereas another study showed that elimination of diazepam is best described by models that embody a low degree of sinusoidal heterogeneity or mixing. To investigate this discrepancy we examined, in the isolated perfused rat liver, the simultaneous elimination of taurocholate and diazepam. The effect on hepatic availability of varying unbound fraction (fu) in a single pass, steady-state system was studied in six experiments for taurocholate (fu, 0.066-0.966) and diazepam (fu, 0.051-0.675) by varying perfusate albumin concentration (0-60 g l-1). As before, elimination of taurocholate was best described by models that embody a high degree of sinusoidal heterogeneity or mixing (i.e., venous equilibrium model, dispersion model with dispersion number = infinity). Diazepam elimination was best described by models that embody a low degree of sinusoidal heterogeneity or mixing (undistributed sinusoidal model, dispersion model with low dispersion number = 1.04). A third model, a distributed model incorporating heterogeneity of sinusoidal blood flows and intrinsic clearances, fitted the data for both taurocholate and diazepam. The fitted coefficients of variation of both flow and intrinsic clearance among the sinusoids were large for taurocholate (176 and 164, respectively), but for diazepam blood flow was large (200) whereas that for intrinsic clearance was small (0.807).(ABSTRACT TRUNCATED AT 250 WORDS)
已经开发了各种动力学模型来描述肝脏对物质的清除,但对于哪种模型最合适尚无定论,因为实验评估不完整且结果相互矛盾。我们之前已经表明,牛磺胆酸盐的肝脏清除最好用体现高度窦状异质性或混合性的模型来描述,而另一项研究表明,地西泮的清除最好用体现低度窦状异质性或混合性的模型来描述。为了研究这种差异,我们在离体灌注大鼠肝脏中研究了牛磺胆酸盐和地西泮的同时清除。在六个实验中,通过改变灌注液白蛋白浓度(0 - 60 g/L),研究了在单通道稳态系统中不同未结合分数(fu)对牛磺胆酸盐(fu,0.066 - 0.966)和地西泮(fu,0.051 - 0.675)肝脏可利用性的影响。和之前一样,牛磺胆酸盐的清除最好用体现高度窦状异质性或混合性的模型来描述(即静脉平衡模型、分散数 = 无穷大的分散模型)。地西泮的清除最好用体现低度窦状异质性或混合性的模型来描述(未分布窦状模型、分散数 = 1.04 的分散模型)。第三个模型,一个包含窦状血流异质性和内在清除率的分布模型,拟合了牛磺胆酸盐和地西泮的数据。牛磺胆酸盐在窦状之间的血流和内在清除率的拟合变异系数都很大(分别为176和164),但对于地西泮,血流变异系数很大(200),而内在清除率的变异系数很小(0.807)。(摘要截断于250字)